SeaStar Medical Holding Corporation - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
ICU Nasdaq 3840 seastarmedical.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for SeaStar Medical Holding Corporation

CEO Chat with Eric Schlorff, CEO of SeaStar Medical Holding Corporation - Feb 2nd, 2026 3:00 am
SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference - Jan 29th, 2026 6:25 am
ICU: Critical Care Innovation for AKI Patients; Initiating Coverage of SeaStar Medical Holding Corp. - Jan 13th, 2026 2:43 am
SeaStar Medical Announces 2026 Milestones - Jan 7th, 2026 6:13 am
SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference - Jan 6th, 2026 6:53 am
SeaStar Medical Announces 1-for-10 Reverse Split - Dec 23rd, 2025 2:25 pm
SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI - Dec 2nd, 2025 6:27 am
SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference - Nov 20th, 2025 7:52 am
SeaStar Medical Announces Appointment of Michael Messinger as CFO - Nov 17th, 2025 6:43 am
SeaStar Medical Holding Corp (ICU) Q3 2025 Earnings Call Highlights: Revenue Surge and ... - Nov 13th, 2025 10:04 pm
SeaStar Medical (ICU) Q3 2025 Earnings Transcript - Nov 13th, 2025 3:45 pm
SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates - Nov 13th, 2025 2:05 pm
Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum - Nov 12th, 2025 6:15 am
SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025 - Nov 5th, 2025 8:03 am
SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children - Sep 29th, 2025 6:36 am
SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury - Sep 24th, 2025 2:22 pm
SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children - Sep 23rd, 2025 6:23 am
SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference - Sep 4th, 2025 4:13 pm
SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival - Sep 2nd, 2025 6:22 am
SeaStar Medical Holding Corp (ICU) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... - Aug 14th, 2025 1:14 am